ArticleJournal of clinical medicine research2019

Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment.

Keisuke Okamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.